Unrelated Cord Blood Transplantation For Infant Acute Leukemia Diagnosed Within 1 Year Of Age: Outcomes and Risk Factor Analysis On Behalf Of Eurocord and PDWP-EBMT
Annalisa Ruggeri(Inserm), Jean‐Hugues Dalle(Inserm), Franco Locatelli(Bambino Gesù Children's Hospital), Karima Yakouben(Délégation Paris 7), Fernanda Volt(Université Paris Cité), Manuel Abecasis(IPO Porto), Éliane Gluckman(Assistance Publique – Hôpitaux de Paris), Marco Zecca(Policlinico San Matteo Fondazione), Tracey O’Brien(Sydney Children's Hospital), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Ajay Vora(Great Ormond Street Hospital), Jacqueline Cornish(Bristol Royal Hospital for Children), Gérard Michel(Hôpital de la Timone), Giorgio Dini, Vanderson Rocha(European Organisation for Rare Diseases), Christina Peters(Cancer Research Institute of the Slovak Academy of Sciences)
Cited by 4
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
|The Lancet Respiratory Medicine|2020|738